Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: Proposal for an easy strategy
- 28 February 2001
- journal article
- case report
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 36 (3) , 352-358
- https://doi.org/10.1002/mpo.1085
Abstract
Background Discrimination between late relapse of acute lymphoblastic leukemia (ALL) and secondary ALL might be clinically important, because the former might still respond favorably to chemotherapy and/or bone marrow transplantation, whereas secondary ALL is associated with poor prognosis. Procedure We present a pre‐B‐ALL patient in whom disease recurred 2 years after completion of treatment. Differences in cytomorphology and immunophenotyping raised a suspicion of secondary ALL. We performed detailed molecular studies of immunoglobulin and T‐cell receptor genes for discrimination between relapsed and secondary ALL. Results Southern blot analysis showed an oligoclonal immunoglobulin heavy chain (IGH) gene configuration at diagnosis and a monoclonal configuration at relapse. The size of one of the rearranged bands at relapse was identical to one of the faint rearranged bands at diagnosis. However, heteroduplex PCR analysis demonstrated that none of the clonal IGH gene rearrangements at diagnosis and at relapse was fully identical. Sequencing of several clonal PCR products revealed an identical DH6‐13↔JH6b junction shared by two different rearrangements at diagnosis and one rearrangement at relapse, thereby proving the clonal relationship between diagnosis and late relapse in this patient. Conclusions We propose a stepwise molecular approach for discrimination between relapsed and secondary ALL based on the rapid and cheap heteroduplex PCR technique, including mixing of clonal (homoduplex) PCR products identified at diagnosis and at relapse. Direct sequencing and comparative sequence analysis of IGH gene rearrangements at diagnosis and at relapse should be regarded as an ultimate standard, but can be limited to the rare cases, in which no identical clonal PCR products at diagnosis and at relapse were detected with the mixed heteroduplex PCR analyses. Med. Pediatr. Oncol. 36:352–358, 2001.Keywords
This publication has 34 references indexed in Scilit:
- Suitable DNA isolation method for the detection of minimal residual disease by PCR techniquesLeukemia, 1999
- Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysisLeukemia, 1999
- Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual diseaseLeukemia, 1999
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual diseaseLeukemia, 1998
- Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferationsLeukemia, 1997
- Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual diseaseLeukemia, 1997
- Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single‐strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detectionBritish Journal of Haematology, 1995
- The human immunoglobulin VH repertoireImmunology Today, 1995